3.4. Safety
fever, chills, sore throat, abdominal pain, back pain, insomnia, runny nose, anorexia, gum pain, lethargy, nausea, hoarse voice, stye, diarrhea, fatigue, cough, nasal congestion, leg pain, swelling, pain, dizziness, skin irritation, headache, phlegm
SORE THROAT, STYE, ADVERSE EVENTS, ADVERSE EVENT, HAND SWELLING, ANOREXIA
No serious adverse events were observed during this study. Newly identified adverse events during the intervention period were 34 in 13 participants in the placebo group and 34 in 16 participants in the OLL2809 group. There were no significant differences in the numbers between the groups. Adverse events included fever, chills, joint pain, runny nose, nasal congestion, sneezing, cough, sore throat, hoarse voice, phlegm, nausea, abdominal pain, diarrhea, vomiting, anorexia, stomach discomfort, fatigue, lethargy, malaise, dizziness, insomnia, headache, back pain, ear pain, skin irritation, rough hands, arm pain, leg pain, gum pain and swelling, swelling of the legs, and stye. All adverse events were determined to be unrelated to the ingestion of the test food because their causes were evident and considered transient or accidental by the physician in charge.